Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Change in Optomed’s holding of treasury shares

Optomed Plc         Stock Exchange Release    6 August 2021 at 13, Helsinki Change in Optomed’s holding of treasury shares Optomed has conveyed 2,461 treasury shares to the members of the Board of Directors as a part of the Board members' annual remuneration in accordance with the decision of the Annual General Meeting 2021. The amount of shares is based on the monthly remuneration decided by the Annual General Meeting and Optomed's value weighted average share price on 4 August 2021. Furthermore, a total of 143,250 of shares have been subscribed for under the Company’s stock

Desert Control AS – Share capital increase registered

ISSUER DESERT CONTROL AS Sandnes, Norway, 6 August 2021: Reference is made to the stock exchange releaseby Desert Control ASA ("Desert Control" or the "Company") published on 5 July2021 regarding purchase of 63,000 shares by the Company's Chief TechnologyOfficer.The purchase of shares was carried out as part of the Company's employeeincentive program and was facilitated by the board of directors of the Company'sresolution on 5 July 2021 to increase the share capital, pursuant to theauthorisation granted by the Company's extraordinary general meeting on 6 April2021. The

BioInvent Announces Second Clinical Trial Collaboration and Supply Agreement to Evaluate BI-1808 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors

· Anti-TNFR2 antibody targets Treg mediated immunosuppression · Agreement supports the strong rationale for combining anti-TNFR2 and pembrolizumab in the ongoing Phase 1/2a trial · BI-1808 is one of three BioInvent drug candidates in clinical development Lund, Sweden – August 6, 2021 – BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV) today announced that it has entered into a second clinical trial collaboration and supply agreement with MSD, a tradename of Merck & Co., Inc., Kenilworth, NJ., USA, to evaluate the combination of BioInvent’s BI-1808, one of its

SAS Traffic figures - July 2021

Increased traveling during the summer resulted in over a million passengers in July.July was a month with increased numbers of travelers. More than a million passengers chose to fly with SAS, which is an increase of almost 70% compared with June. Capacity was raised during the month with increased frequency and destinations. The load factor ended at 60%, which is the highest number since February 2020. “We see the numbers improving gradually which is pleasing. However, we do naturally remain cautious as there are still a high number of uncertainties ahead of us. Remaining travel

David Phillips appointed Head of UK and Investor Relations of Aker Carbon Capture

David Phillips has been appointed Head of UK and Investor relations for Aker Carbon Capture effective August 1, 2021. He will also support Aker Horizons on investor relations.Phillips joins the company from HSBC’s Global Banking & Markets business, where he worked in London as Head of Equity Research for Europe, and before this in New York as Global Head of Resources & Energy Research. Phillips’ previous experience also includes roles at Aker Solutions, where he was responsible for Industry & Investor Relations.  “We are excited to welcome David Phillips back to the Aker family, in

SynAct Pharma strengthens its organization with two key recruitments

SynAct Pharma AB (“SynAct”) today announced the appointments of Patrik Renblad as Vice President Finance and Lise Agersted as Director of Operational R&D. Mr. Renblad will be responsible for the finance function reporting to the CFO. Mrs. Agersted will report to the CSO. Both starts immediately.Mr. Renblad joins SynAct after a decade in various financial roles at LEO Pharma A/S, where he was most recently Finance Director, R&D, leading the R&D Business Finance Organization and was a member of the LEO Pharma Finance and R&D Leadership teams. Prior to LEO Pharma, Mr. Renblad worked nine years

Bulletin from Extraordinary General Meeting in CELLINK AB (publ)

At the extraordinary general meeting in CELLINK AB (publ), held on August 6, 2021, the following resolutions were passed. The extraordinary general meeting resolved, in accordance with the proposal by the board of directors, to change the company name from CELLINK AB (publ) to BICO AB (publ) provided registration of the Swedish Companies Registration Office and to change the company’s objects in accordance with the following; The company shall acquire, own and manage real-, movable- and intellectual property, and mainly through subsidiaries conduct development, manufacturing and sale of

Contract extension for CSV Normand Pacific

Solstad Offshore ASA is pleased to announce that Prysmian Powerlink Srl (“Prysmian”) has exercised their option to extend the firm contract for CSV Normand Pacific with one year. The firm period will expire on December 31[st], 2022. In addition, Prysmian has the option to extend the contract with 2 years beyond the firm period. Normand Pacific has been on charter with Prysmian since August 2016. Skudeneshavn, August 6[th], 2021 ContactsLars Peder Solstad CEO, at +47 91 31 85 85Kjetil Ramstad CFO, at +47 90 75 94 89 Solstad Offshore ASAwww.solstad.com

Contract award in Brazil

Solstad Offshore ASA is pleased to announce a new contract for the CSV Normand Flower with PETROBRAS. The contract is for 3 years firm with 475 days options thereafter. Normand Flower will sail under REB Flag, supporting exploration and production activities in Brazilian continental shelf. Commencement of the contract will take place within April 2022. Skudeneshavn, August 5[th], 2021 Contacts Lars Peder Solstad CEO, at +47 91 31 85 85Kjetil Ramstad CFO, at +47 90 75 94 89 Solstad Offshore ASAwww.solstad.com

EAB Group Plc’s Board of Directors has decided on distribution of dividend

EAB Group Plc, Other information disclosed according to the rules of the Exchange, Stock Exchange Release, 6 August 2021, 9:10 a.m. (EET) EAB Group Plc’s Board of Directors has decided on distribution of dividend The Board of Directors of EAB Group Plc has decided to distribute a dividend of EUR 0.05 per share to shareholders in accordance with the mandate received from the Annual General Meeting (“AGM”) in 2021. The dividend of EUR 0.05 per share will be paid to shareholders who on the record date for the dividend payment on 31 August 2021 are recorded in EAB Group’s shareholders’

BERGENBIO ANNOUNCES CHANGES TO SENIOR MANAGEMENT

Bergen, Norway, 6 August 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, today announces changes to its clinical development team structure in preparation for late-stage clinical trials of lead candidate bemcentinib and increased activity in medical and scientific regulatory affairs. Prof. Hani Gabra has transitioned from Chief Medical Officer to a part-time position as Director of Clinical Development, to focus on the scientific elements of clinical trial design and the

Artificial Solutions: Invitation to presentation of Q2 report 2021

Artificial Solutions® (SSME:ASAI), the leading specialist in enterprise-strength conversational AI, will release the interim report for the second quarter of 2021 on Tuesday 10th August at 07:30am (CET)The full report and a brief presentation will be available on: https://www.investors.artificialsolutions.com/financial-reports.Conference Call – DetailsPer Ottosson, CEO and Fredrik Törgren, CFO will present the financial results at a telephone conference at 10:00 CET on the same day. To participate in the conference call, please use the dial-in details below. Callers are encouraged to

Interim Report January – June 2021

Highlights Financial · Streaming sales up 19% from Q2 2020 to 545 (459) MSEK, +22% with constant exchange rates · Subscriber base up 29% from Q2 2020 to 1,626,900 (1,257,000) on average · Net turnover increased to 641 (554) MSEK in Q2 2021 · Earnings per share, after taxes amounted to -2.04 (-0.91) SEK in Q2 2021, before and after dilution Other · Held the Annual General Meeting of Shareholders on May 4 · Signed agreement to acquire the Finnish publishing house Aula & Co AB · Entered into a partnership with Spotify making Storytel’s catalogue available on the

Irisity AB (publ) delivers a second quarter with strong growth

The CEO comments on the second quarter: Net sales during the period amounted to SEK 13.1 million (9.6) and capitalized work to SEK 2.8 million (1.0). EBITDA amounted to SEK -2.6 million (-0.1) and profit after tax to SEK -6.0 million (-3.5). The gross margin was 58.2 percent (67.6). Cash and cash equivalents at the end of the period SEK 47.5 M (30.6). We finished the second quarter strong with net sales increasing by 36 percent and monthly recurring revenue (MRR) by 58 percent on a quarterly basis. During the period gross margin and EBITDA were burdened by new recruitments and many

Mika Vehviläinen selected as President and CEO of the Future Company as from completion of the merger between Konecranes and Cargotec

KONECRANES PLC INSIDE INFORMATION August 6, 2021 at 9:00 EEST Mika Vehviläinen selected as President and CEO of the Future Company as from completion of the merger between Konecranes and Cargotec On 1 October 2020, Konecranes Plc (“Konecranes”) and Cargotec Corporation (“Cargotec”) announced that the boards of the companies had signed a combination agreement and plan to combine the two companies through a merger (the “Future Company”), subject to regulatory and other approvals (the “Transaction”). The Boards of Directors of Konecranes and Cargotec have agreed to select Mr. Mika

Invitation to a press conference: Kamux Corporation’s Half-Year Report for January—June 2021

Kamux Corporation     Investor News      August 6, 2021 at 9:00 (EEST) Invitation to a press conference: Kamux Corporation’s Half-Year Report for January—June 2021 Kamux Corporation will publish its Half-Year Report for January-June on August 13, 2021 at about 9:00 a.m. Kamux will hold a Half-Year Report press conference and webcast for media and analysts on Friday August 13, 2021 at Hotel Kämp, Symposion meeting room (address Pohjoisesplanadi 29, Helsinki) at 11:00 (EEST) in Finnish and then in English at around 12:00 (EEST). You can follow the live webcast in Finnish through a

EAB Group Plc’s half-year report for January–June 2021: The Group's operating income increased by 21% and the result for the period improved by EUR 1.6 million

EAB Group Plc, Stock Exchange Release, 6 August 2021, 9:00 a.m. (EET) EAB Group Plc’s half-year report for January–June 2021: The Group's operating income increased by 21% and the result for the period improved by EUR 1.6 million In January–June 2021, the EAB Group's (later EAB or the Group) operating income increased by 21% and the result improved by EUR 1.6 million from the comparison period (EUR 0.8 million result in H1/2021 and EUR 0.75 million loss in H1/2020) as a result of increased operating income and efficiency measures introduced in 2020. The Group's continuing operating

NURMINEN LOGISTICS PLC HALF-YEAR FINANCIAL REPORT 1 JANUARY–30 JUNE 2021

Nurminen Logistics Plc                                                   Half-year Financial Report August 6, 2021 at 9:00 a.m.   Growth at the beginning of the year was very strong. Net sales increased by 73 per cent to EUR 63.0 million and net operating profit improved to EUR 3.7 millionThis release is a summary of Nurminen Logistics' Half-year Financial Report January-June 2021. The full report is attached to this stock exchange release and is available on Nurminen Logistics' website at nurminenlogistics.com  KEY FIGURES 1.1.–30.6.2021 1.1.–30.6.2020

President and CEO Rob Smith to leave Konecranes

KONECRANES PLC STOCK EXCHANGE RELEASE August 6, 2021 at 8:58 EEST President and CEO Rob Smith to leave Konecranes Konecranes President and CEO Rob Smith has decided to leave the company. He will leave Konecranes on 31 December 2021. The company's CFO, Teo Ottola, who also serves as Deputy CEO, will be acting as the interim CEO from 1 January 2022 until the completion of the planned merger between Konecranes and Cargotec Corporation, which is currently expected by the end of H1/2022. “Rob has been a true leader for Konecranes since joining in February 2020, steering the company

Half-Year Report 1 January – 30 June 2021

Qt Group Plc Stock Exchange Release 6 August 2021 at 8:00 a.m. Second quarter: Comparable net sales nearly doubled, we raise net sales outlook in comparable currencies to 40-50 percent. April–June 2021 •    Net sales increased by 87.6 percent to EUR 33,925 thousand (18,081)*. The effect of exchange rates on the comparison period’s net sales was negative EUR 906 thousand. At comparable exchange rates, net sales increased by 97.5 percent.•    The operating profit (EBITA) was EUR 11,417 thousand (3,721) or 33.7 (20.6) per cent of net sales.•    The operating profit (EBIT) was

Bittium Corporation Half-Year Financial Report January-June 2021

Stock exchange release Free for publication on August 6, 2021 at 8.00 am (CEST +1) Bittium Corporation Half-Year Financial Report January-June 2021 Bittium’s Operating Result Turned Positive During the Second Quarter of the Year Unless otherwise mentioned, the figures in brackets refer to the corresponding period in the previous year.  Summary April-June 2021 · Net sales was EUR 22.6 million (EUR 25.3 million), representing 10.4 percent decrease year-on-year. · The share of product-based net sales was EUR 16.7 million (EUR 18.4 million), representing 73.8 percent of

Continued good sales for Clas Ohlson in July

Sales in July were unchanged and amounted to 732 MSEK (733). Organic sales were unchanged compared to the previous year. Sales in comparable units and local currency decreased by 1 per cent compared to the previous year. Online sales increased by 15 per cent to 62 MSEK (54). Compared to the same month last year the store network increased by one store. At the end of the period the total number of stores was 229 (228).Distribution of sales Month Accumulated July Change May - July ChangeMSEK 2021/22 SEK

Inzile has signed revised conditional agreement regarding acquisition of QEV Tech Holdings

Inzile AB (publ) (“Inzile”) has entered a revised conditional agreement to acquire 80% of the Spanish company QEV Tech Holdings (“QEV Holdings”), which in turn is a part-owner of the Spanish company QEV Technologies SL (“QEV Tech”).After intensive negotiations between the principal owners of the parties Inzile and QEV Holdings, a revised solution for a collaboration has been reached, giving Inzile 80% of the shares of QEV Holdings, which in turn owns 19,64% of the shares of QEV Tech. This agreement is subject to the conditions listed below. At an extra shareholders’ meeting Inzile will

Norway Royal Salmon ASA (NRS): Acceptances received under mandatory offer to acquire all shares in Norway Royal Salmon ASA

Reference is made to the mandatory offer (the "Offer") from NTS ASA (the "Offeror") to acquire all shares in Norway Royal Salmon ASA ("NRS" or the "Company") pursuant to an offer document dated 16. July 2021, at an offer price of NOK 209 per share and with an offer period from 19 July 2021 to 16 August 2021 at 16:30 CEST (subject to extension) (the "Offer"). On 5 August 2021, the Offeror received acceptance under the Offer for 589 shares. The Offeror has during the Offer Period received acceptances for in total 3,358 shares in NRS. In addition, NTS has acquired 601,871 shares in NRS over

There are no items matching the current filter
There are no more items matching the current filter
Back to top